The present value of human life losses associated with COVID-19 and likely productivity losses averted through COVID-19 vaccination in Madagascar
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Madagascar
Area Of Science
- Public Health
- Health Economics
- Epidemiology
Background
- Madagascar reported 1,422 COVID-19 deaths by March 3, 2023.
- No prior studies estimated the Total Present Value of Human Life lost (TPVHL) or productivity losses in Madagascar due to COVID-19.
Purpose Of The Study
- To estimate the TPVHL and productivity losses from COVID-19 deaths in Madagascar.
- To quantify potential productivity gains from COVID-19 vaccination for advocacy.
Main Methods
- Utilized the Human Capital Model (HCM) to calculate TPVHL across seven age groups.
- Calculated Present Value of Human Life (PVHL) using discount factors, life expectancy, GDP per capita, and COVID-19 mortality.
- Performed sensitivity analyses with varying discount rates, life expectancies, excess mortality projections, and vaccine coverage levels.
Main Results
- The 1,422 COVID-19 deaths represented a TPVHL of Int$46,331,412 (average Int$32,582 per life).
- Sensitivity analyses showed significant impact of discount rates and life expectancy on TPVHL.
- Projected excess mortality substantially increased TPVHL, while 70% vaccine coverage could save Int$1.1 billion (1.94% of GDP).
Conclusions
- COVID-19 has caused substantial health and economic losses in Madagascar.
- Optimizing COVID-19 vaccination coverage is crucial for mitigating these losses.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
